Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Nancy Sweitzer
SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart
Coronavirus disease (COVID-19) is a serious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The symptoms of the disease range from asymptomatic to mild respiratory symptoms and even potentially life-threatening cardiovascular and pulmonary complications. Cardiac complications include acute myocardial injury, arrhythmias, cardiogenic shock and even sudden death.
Impact of pulmonary disease on the prognosis in heart failure with preserved ejection fraction: the TOPCAT trial
Research Letter PDF PDF Share No abstract is available for this article. Supporting Information Filename Description ejhf1593-sup-0001-Tables.docxWord 2007 document , 33.4 KB Table S1. Baseline clinical characteristics in the study sample overall and stratified by the presence of pulmonary disease. Table S2. Baseline clinical characteristics, stratified by the presence of pulmonary disease and randomization treatment assignment. Table S3. Impact of randomized treatment allocation (spironolactone vs.
Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trial
We analysed participants from the Americas from the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) study with available baseline and 8-week visit SBP data (n?=?1645). We related baseline SBP to several efficacy and safety outcomes.
Influence of ejection fraction on cause-specific mortality in heart failure with preserved ejection fraction
Research LetterInfluence of ejection fraction on cause-specific mortality in heart failure with preserved ejection fractionAuthorsNavkaranbir S. Bajaj,Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USASearch for more papers by this authorBrian Claggett,Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USASearch for more papers by this authorEldrin F.
Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction
Of 3445 patients with HFpEF enrolled in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, dyssynchrony analysis was performed on 424 patients (12%) by multiple speckle tracking echocardiography strain-based criteria. The primary dyssynchrony analysis was the standard deviation of the time to peak longitudinal strain (SD T2P LS).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Nancy
Contact Nancy, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack